SCHEMBL3720593

SCHEMBL3720593

CCOC(=O)C(C)CN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HTT P42858 3/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
USP2 O75604 1/20 0.43
ABCB1 P08183 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2529176 0.87 ALDH1A1 (0.48) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL2529177 0.87 ALDH1A1 (0.48) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL27557042 0.86 ALDH1A1 (0.44) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL1705499 0.84 ALDH1A1 (0.49) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL3158801 0.82 USP2 (0.45) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL18852406 0.82 PIK3CD (0.58) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL1189317 0.81 ALDH1A1 (0.56) ALDH1A1HTTMAPTKDM4ESMN1; SMN2
SCHEMBL21564360 0.81 HPGD (0.45) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL31082333 0.81 HPGD (0.45) ALDH1A1HTTMAPTNPC1MAPK1
SCHEMBL16825817 0.80 USP2 (0.49) ALDH1A1HTTMAPTNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138589-A1 BICYCLIC PYRIMIDINE PI3K INHIBITOR COMPOUNDS SELECTIVE FOR P110 DELTA, AND METHODS OF USE GENENTECH, INC. (US) 2010-12-02 WO disclosed
EP-1812445-A1 PHARMACEUTICAL COMPOUNDS Piramed Limited (GB) 2007-08-01 EP disclosed
WO-2006046031-A1 PHARMACEUTICAL COMPOUNDS PIRAMED LIMITED (GB) 2006-05-04 WO disclosed